---
title: ePrescribe | Nextvisit
description: Surescripts-certified ePrescribe with EPCS, behavioral-health interaction checks, and MAT-ready buprenorphine. Same workspace as the chart.
url: "http://localhost:3000/eprescribe"
type: static
generatedAt: "2026-09-04T06:57:01.404Z"
---

ePrescribe
# Prescribe in the encounter, not in another tab.

Surescripts-certified, with EPCS and real-time benefit checks. Interaction checks are tuned for psych and addiction-medicine combinations.

ePrescribe is a paid add-on, priced per provider. Surescripts onboarding, EPCS identity proofing, and two-factor enrollment happen in the platform. Most solo and small groups prescribe within a week.
  [Start in minutes](https://nextvisit.app/register) [Talk to sales](mailto:sales@nextvisit.ai)
Already on Nextvisit? Add ePrescribe from the workspace settings. [Sign in](https://nextvisit.app/login) to enable.
         Sertraline HCl 100 mg oral tablet1 tab PO daily · qty 30 · 1 refillNDC 0093-7199Generic OKSchedule IV
1. AllergiesNKDA on file. No conflicts with sertraline.
1. Drug interactionsCross-checked 4 active meds (alprazolam, lithium, propranolol, melatonin). No critical interactions.
1. Dose for age and indication50 mg → 100 mg titration appropriate for adult MDD per FDA labeling.
1. QTc advisoryBaseline ECG advised if escalating beyond 200 mg or combining with other QT-prolonging agents.
1. EPCS not requiredSchedule IV. Standard e-prescribe path applies.
Aetna PPO·Tier 1·$0 copay·No prior authSurescripts→CVS Pharmacy #043211281 Avenue of the Americas, New York NY·1932•••743
Sample data. Live orders use the patient roster, plan on file, and pharmacy preferences.

### Serotonin syndrome

SSRI plus MAOI combinations flag at order entry. Tramadol, linezolid, and methylene blue also surface.

### Lithium toxicity

NSAID, ACE inhibitor, and thiazide combinations prompt a level-check reminder. Lithium level cadence follows the dosing pattern on file.

### QT prolongation

Citalopram, ziprasidone, methadone, and combinations among them trigger a QTc advisory, with a baseline ECG suggestion when you plan to escalate.

### Buprenorphine and benzodiazepines

The combination is not contraindicated. The system surfaces the overdose risk and the documentation requirements at order entry.

 - Immutable audit log of every send, retraction, and refill.
- Schedule II for stimulants, opioids, and benzodiazepines.
- DEA 21 CFR 1311 EPCS rule compliant.
        Two-factor required   Buprenorphine 8 mg / Naloxone 2 mg Schedule III · sublingual film · qty 14 · 0 refills   Authenticator code  42••••
The audit log captures send time, IP, device fingerprint, and EPCS proof.

 - Copay estimate (covered amount, deductible status, OOP impact).
- Prior-auth flag, with the form pre-populated when PA is required.
- Therapeutic alternatives when the chosen drug is not covered.
        Aetna PPO Behavioral Health    Formulary tier Tier 1 (preferred generic)   Estimated copay $0   Prior authorization Not required   Alternatives None needed
Most behavioral-health clinicians are now MAT-eligible by default. Nextvisit handles EPCS for buprenorphine (Schedule III), prior-auth checks for some payers, and 42 CFR Part 2 documentation. Dedicated MAT panels use cohort tags and outcome tracking on the [MAT solutions page](/for-mat).
  [MAT and addiction medicine](/for-mat) [Insurance and billing](/insurance-and-billing)
###

Nextvisit ePrescribe is Surescripts-certified. It supports EPCS for Schedule II to V, behavioral-health interaction and dose-for-age checks, and routes to the patient's pharmacy.

###

Yes, for Schedule II to V. Two-factor at every send. The audit log is immutable and meets DEA 21 CFR 1311. Common Schedule II work includes stimulants and, in some states, certain benzodiazepines. Buprenorphine/naloxone combinations are Schedule III.

###

Yes. The X-waiver ended in December 2022 under the Mainstreaming Addiction Treatment Act. A standard DEA registration and the 8-hour MAT training are enough. Nextvisit handles EPCS, interaction checks, and MAT documentation.

###

The new prescription is checked against the patient's active meds at order entry. Alerts focus on serotonin syndrome, lithium toxicity, QT prolongation, and benzodiazepine plus opioid combinations.

###

Yes. It fires at order entry and returns formulary tier, copay estimate, prior-auth flag, and therapeutic alternatives if the drug is not covered. The PA form is pre-populated when one is needed.

###

Any pharmacy that accepts Surescripts, including CVS, Walgreens, Walmart, Rite Aid, Kroger, independents, and mail-order. Patients pick a pharmacy at any visit.

###

Surescripts onboarding, plus EPCS identity proofing and two-factor enrollment per provider, handled in the platform. Most solo and small groups prescribe within a week. Enterprise and academic sites that need credentialing-board sign-off run on their own timeline.

###

Yes, on the medications chart. Switch proposes a day-by-day cross-taper or washout for catalog antidepressants and common behavioral-health antipsychotics, with the reason in plain language. You accept, edit, or reject. MAOI pairs stay on a washout. Mood stabilizers, benzodiazepines, and stimulants are not in this catalog. The schedule is a rules table, not a model, and you still own the prescription.
             Try it next visit
## Twenty minutes, one mock visit. You leave with a note in your template.

Enable ePrescribe and run an EPCS send against a sandbox pharmacy in the first week.
  [Start in minutes](https://nextvisit.app/register) [Talk to sales](mailto:hello@nextvisit.ai)     Live in 2 weeks or less   BAA signed by default